Both BioNTech and Pfizer said Tuesday that they have acquiesced Covid-19 vaccine data on children ages 5 to 11 to the FDA (Food and Drug Administration) for primary review, but till now there are not yet looking for emergency use approval. Companies said that a formal submission to demand EUA for the vaccine is probable … Read More
On Monday, President Joe Biden received his COVID 19 booster dose, the day after the federal controllers suggested a third dose of the Pfizer vaccine for the American citizens who is 65 or older and approved them for others with pre-existing medical circumstances and high-risk work atmospheres. “The most crucial thing we need to do … Read More
Recently U.S. health authorities confirmed that more than 40 million doses of coronavirus vaccines are available and they are confident that these doses will be sufficient for both qualified older American citizens seeking booster shorts and the children for whom early vaccines are estimated to be permitted in near future. The increase in demand -predictable … Read More
It follows a reference from the government’s vaccine advisers, the JCVI, who recently said about 30 million people should be provided with a third dose of the vaccine. They said the booster should be given at least six months’ gap after a person had their second dose of the vaccine- with the Pfizer-BioNTech jab recommendation. … Read More
Is the delta variant of the Coronavirus worse for kids? This is now a debate among people, but according to the research of health experts, there is no such strong evidence yet that it affects children and teens sicker than earlier versions of the COVID virus, though delta variant has headed to a rush in … Read More
The United States will purchase 500 million more doses of the Pfizer coronavirus vaccine to donate the needy countries, in a recent statement, President Biden declared at a virtual summit on the pandemic that the United States is almost doubling its purchase of vaccine to 1 billion and Biden expecting 70% of the world’s population … Read More
